See also this year's filing and all EDGAR filings for this company.
PDF Report 0000880771_2017_Sciclone_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000880771, Sciclone Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 195,733,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 30,838,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,002,000 |
| 3 | remainder_Assets | 13,325,000 |
| 4 | LiabilitiesCurrent | 26,441,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 34,181,000 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 96,084,000 |
| 11 | remainder_Revenues | 160,096,000 |
| 12 | remainder_NetIncome | 898,000 |
| 13 | remainder_ComprehensiveNetIncome | -3,590,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 241,898,000 |
| 1 | Liabilities | 26,441,000 |
| 2 | Expenses | 130,265,000 |
| 3 | Revenues | 160,096,000 |
| 4 | StockholdersEquity | 215,457,000 |
| 5 | NetIncome | 30,729,000 |
| 6 | ComprehensiveNetIncome | 28,934,000 |
| 7 | BaseVar | 281,594,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.72 |
| 9 | EconomicCapitalRatio | 4.18 |
Edgar->Model Mapping
Feature Distribution
Change over Time
